Cargando…
Mechanism of double-base lesion bypass catalyzed by a Y-family DNA polymerase
As a widely used anticancer drug, cis-diamminedichloroplatinum(II) (cisplatin) reacts with adjacent purine bases in DNA to form predominantly cis-[Pt(NH(3))(2){d(GpG)-N7(1),-N7(2)}] intrastrand cross-links. Drug resistance, one of the major limitations of cisplatin therapy, is partially due to the i...
Autores principales: | Brown, Jessica A., Newmister, Sean A., Fiala, Kevin A., Suo, Zucai |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2475632/ https://www.ncbi.nlm.nih.gov/pubmed/18499711 http://dx.doi.org/10.1093/nar/gkn309 |
Ejemplares similares
-
Quantitative analysis of the efficiency and mutagenic spectra of abasic lesion bypass catalyzed by human Y-family DNA polymerases
por: Sherrer, Shanen M., et al.
Publicado: (2011) -
Mechanistic consequences of temperature on DNA polymerization catalyzed by a Y-family DNA polymerase
por: Fiala, Kevin A., et al.
Publicado: (2008) -
Significant contribution of the 3′→5′ exonuclease activity to the high fidelity of nucleotide incorporation catalyzed by human DNA polymerase ϵ
por: Zahurancik, Walter J., et al.
Publicado: (2014) -
Structural and kinetic insights into binding and incorporation of L-nucleotide analogs by a Y-family DNA polymerase
por: Gaur, Vineet, et al.
Publicado: (2014) -
DNA polymerase minor groove interactions modulate mutagenic bypass of a templating 8-oxoguanine lesion
por: Freudenthal, Bret D., et al.
Publicado: (2013)